Dead Sea Conference October 11-13, 2023 Registration Open For Dead Sea Conference “The Disease Prevention, Detection and Treatment Conference: A unique meeting on Precision Medicine will be led by top professionals whose expertise is in discovery and use of molecular data to improve health. More than 80 international experts have already approved their participation and will lead parallel sessions
Register for the 1st African Pharmacogenomics Network Webinar. Facebook Twitter LinkedIn We highly recommend checking out the 1st African Pharmacogenomics Network Webinar debuting this July. This is a webinar series aimed at raising awareness around the importance of pharmacogenomics for African populations. Join every last Thursday of the month, from the African Pharmacogenomics Network (APN) and the African Society of Human
FHH Flagship Project Members To Collaborate on Study To Assess Genetic Services at Dhulikhel Hospital, Nepal
Two members of the Family Health History (FHH) Flagship Project are collaborating on a research study entitled Current Practice and Perspective for enhancing genetic services: An exploratory mixed-method study at Dhulikhel Hospital.
The Genomic Medicine Clinics for Rare Genetic Disorders pilot project completed its initial goal of implementing exome sequencing for the diagnosis of rare uncharacterized and undiagnosed diseases in six clinical sites located in low- and middle-income countries.
We are pleased to share that Teji Rakhra-Burris, GGMC President & CEO, and Dr. Bruce Korf, Interim Co-Chair of G2MC, will represent the Global Genomic Medicine Consortium (G2MC) on the National Academies of Science, Engineering, and Medicine (NASEM) Roundtable on Genomics and Precision Health.
Two members of the Family Health History (FHH) Flagship Project co-authored a paper that presents a list of 25 questions a doctor may use to review a family health history app for clinical quality.
We are excited to share that GGMC will be represented on the Human Genome Organization (HUGO) Forum, where members of the HUGO executive board, committee chairs, and liaisons from other organizations can meet, exchange information and discuss new collaborative initiatives in the genomics arena.
Bill & Melinda Gates Foundation Grand Challenges Funding Opportunity: “Catalyzing Equitable Artificial Intelligence (AI) Use”
The Bill & Melinda Gates Foundation today launched a new Grand Challenges (GC) request for proposals, “Catalyzing Equitable Artificial Intelligence (AI) Use”. The funding level is a grant of up to USD $100,000.00, for each project. Deadline for proposals is June 5, 2023.
Upcoming Talk: “Factors predicting who will stick with a lifestyle intervention: Utilizing precision medicine to improve healthy lifestyle behaviors” will be presented by Katherine Collins, PhD, on Thursday, May 25, 2023. Registration is required.
GA4GH’s is Accepting Submissions for Driver Projects The Global Alliance for Genomics and Health (GA4GH) has issued a call for new Driver Projects to join a rapidly expanding community that boosts responsible genomic data sharing to benefit human health. Groups with projects to embed genomics in healthcare, set genomic data sharing policies, expand data access for specific diseases, and achieve
Read the latest updates from the FHH Flagship Project group.
G2MC Early Career Investigator Profile: Tania Vasquez G2MC is excited to speak with our latest Early Career Investigator looking to invigorate the next era of Genomic Medicine – Tania Vasquez, a House Officer located in Brooklyn, New York. “I am a House Officer at a pediatrics clinic, mostly serving the Hispanic population in Brooklyn, including children with genetic and developmental
Announcing the Appointment of Tejinder K. Rakhra-Burris as President & CEO of the Global Genomic Medicine Collaborative GGMC has formally appointed Tejinder K. Rakhra-Burris as the President & CEO of GGMC, for a term of 5 years, with collective agreement effective 1/30/2023 We’re excited to announce Executive Director Tejinder Rakhra-Burris’ appointment to President and CEO of the Global Genomic Medicine
G2MC Appoints Interim Co-Chair as Founding Co-Chair Finishes Term We are pleased to announce the appointment of Bruce Korf, MD, PhD (USA), as G2MC Interim Co-Chair for 2023. Dr. Korf has actively contributed to the growth of G2MC over the years, serving as a member on the Steering Committee, co-chair of the Education Working Group, and co-host of the past
Register Today for Merck’s Innovation Cup Merck is now taking applications for its Innovation Cup 2023 event! As part of the Innovation Cup, selected applicants join a week-long summer camp, to work together in a highly stimulating environment. Work as part of a team to generate new ideas in the fields: oncology, immuno-oncology, autoimmunity, small molecules drug discovery,
The Rare and Unknown Disease Project is an interdisciplinary 4-year project, funded by the Chilean Agency for Research and Development (ANID) and is aimed at evaluating the personal, familial, healthcare and societal implications of reaching a diagnosis (or not) via exome sequencing for persons with unknown rare disorders in Chile.
The Department of Anatomy, Genetics and Biomedical Informatics at the Faculty of Medicine, University of Colombo, Sri Lanka successfully implement short course to equip medical doctors to integrate genetic and genomic information into their routine clinical practice.
The Rare Disease Project was recently awarded funding by the National Agency for Research and Development (ANID-Chile) for high throughput genotyping equipment, the first in Chile.
The hosting or distribution of any promotional material, links, or sessions on the GGMC or its affiliated websites does not indicate an endorsement by GGMC of the products or services promoted, the company, or the claims made. GGMC does not sell, rent, or share member contact information. Any additional information you choose to share will be shared by you with the company directly, and you may request to be removed from their mailing lists at any time.